Bayer Investor Relations

A bird's eye view of a building with a logo on it.
Investor News
May 30, 2024
Not intended for UK Media
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel
May 28, 2024
World Seed Congress 2024:
Bayer advances genome-editing initiatives for nutrition enhanced vegetables
May 16, 2024
Not intended for UK Media – Late-breaking data from pivotal Phase III studies OASIS 1 and 2 to be presented at 2024 ACOG Annual Meeting:
Elinzanetant significantly reduces frequency and severity of moderate to severe hot flashes associated with menopause